Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
Chien-Hsiung LaiYao-Hsu YangPau-Chung ChenYing-Chi KingChia-Yen LiuPublished in: Pharmacoepidemiology and drug safety (2017)
Interferon-ribavirin therapy was associated with a 53.3% increased risk of retinal vascular complications compared with not receiving the therapy. Regular ophthalmologic examination is essential for patients receiving interferon-ribavirin, particularly those with hypertension.